Loading clinical trials...
Loading clinical trials...
This study is a multicenter, randomized, double-blind, placebo controlled, parallel group study of a seven-week ascending dose period of SLV308 adjunctive to L-dopa treatment in patients with advanced...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Solvay Pharmaceuticals
NCT07536022 · Parkinson's Disease
NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more
NCT07636720 · Parkinson's Disease and Parkinsonism, Dyssomnia
NCT06916507 · Parkinson's Disease
NCT07398157 · PD - Parkinson's Disease
Site 16
Plovdiv
Site 11
Sofia
Site 12
Sofia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions